The effects of treating lower urinary tract symptoms on health-related quality of life: A short-term outcome

Singapore Medical Journal

Volumn 43, Issue 8, 2002, Pages 391-398

  Quek, K F ^a   Loh, C S ^b   Low, Wah Yun ^a   Razack, A H ^c   Chua, C B ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Sunway Medical Centre   (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

Health Related Quality of Life; International Prostate Symptom Score; Lower urinary tract symptoms; Present Pain Intensity; Visual Analogue Scale

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; HEALTH STATUS; HUMAN; MALAYSIA; MALE; MICTURITION DISORDER; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; TIME; TRANSURETHRAL RESECTION;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; AGED, 80 AND OVER; HEALTH STATUS; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PAIN; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; URINATION DISORDERS;

EID: 0036688757     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lai MK. Recent advances in the treatment of benign prostatic hyperplasia. J Formosa Med Assoc 1996; 95:822-7.
2. Garraway WM, Russell EBAW, Lee RJ, Collins GN, McKelvie GB, Hehir M, Rogers CAN, Simpsons RJ. Impact of previously unrecognised benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract 1993; 43:318-21.
3. Naughton MJ, Wyman JF. Quality of life in geriatric patients with lower urinary tract dysfunction. Am J Med Sci 1997; 314:219-27.
4. Tsang KK, Garraway WM. Impact of benign prostatic hyperplasia on general well-being of men. Prostate 1993; 23:1-7.
5. Alexander RB, Trissel D. Chronic prostatitis: results of an internet survey. Urology 1996; 48:568-74.
6. Trapeznikova MF, Bazaev VV, Urenkov SB. Transurethral resection in patient with benign prostatic hyperplasia complicated by chronic calculous prostatitis. Urol Nefrol Mosk 1997; 1:28-31.
7. Mebust WK, Donavan J, Bosch R, Okada K, O'Leary M, Batista J, Villers A, Ackerman R, Hoke G, Lukacs B, Mortensen, S. Symptoms evaluation, quality of life and sexuality. The 3rd International Consultation on Benign Prostatic Hyperplasia (BPH). Monaco, Scientific Communication International Ltd; 1995.
8. Brislin RW. Back-translation for cross-cultural research. J Cross-Cultural Psychology 1970; 1:185-216.
9. Melzack R. The Short-Form McGill Pain Questionnaire. Pain 1987; 30:191-7.
10. Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths, Murphy G. The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). Scientific Communication International Ltd; 1993;p555.
11. Lukacs B, Leplege A, McCarthy C, Comet D. Construction and validation of a BPH specific health related quality of life scale (with special attention to sexuality) for medical outcome research studies; in Cockett ATK, Khoury S, Aso Y, et al (eds): Proceedings of the Second International Consultation on Benign Prostatic Hyperplasia (BPH). Paris, Scientific Communication International; 1994; p139-43.
12. Craigen AA, Hickling JB, Saunders CRG. Natural history of prostatic obstruction. J R Coll Gen Pract 1969; 18:226-32.
13. Birhoff JD, Wiederhorn AR, Hamilton ML, Zinsser HH: Natural history of benign prostatic hypertrophy and acute urinary retention. Urology 1976; 8:48-52.
14. Ball AJ, Feneley RCL , Abrams PH. The natural history of untreated prostatism. Br J Surg 1981; 53:613-6.
15. Fowler FJ Jr, Wennberg JE, Timothy RP, Barry MJ, Mulley AGJr , Hanley D. Symptom status and quality of life following prostatectomy. JAMA 1988; 259:3018-22.
16. Kirby R, Fitzpatrick J, Kirby M, Fitzpatrick A. Shared care for prostatic diseases. ISIS Medical Media. Merck Frosst Canada Inc. Oxford. UK. 1994; 1-35p.
17. Homma Y, Kawabe K, Tsukamoto T, Yamanaka H, Okada K, Okajima E, Yoshida O, Kumazawa, Fang Liu G, Chngwook L, Hsu TC, dela Cruz RC, Tantiwang A, Lim PHC, Sheikh MA, Bapat SO, Marshall VR, Tajima K, Aso Y. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the IPSS. Int Urol 1997; 4:40-6.
18. Fang Liu G. Changes in the prevalence of benign prostatic hyperplasia in China. Chinese Medical Journal 1997; 110:163-6.
19. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen CJ, Lieber MM. The prevalence of prostatism: a population based survey of urinary symptoms. J Urol 1993; 150:85-9.
20. Norman RW, Nickel JC, Fish D, Pickett SN. "Prostate-related symptoms" in Canadian men 50 years of age or older: prevalence and relationship among symptoms. Br J Urol 1994; 74:542-50.
21. Bosch JLHR, Hop WCJ, Kirhels WJ, Schroeder FH. The International Prostate Symptom Score in a community-based sample of men between fifty five and seventy-five years of age. Prevalence and correlation of symptom with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995; 75:622-30.
22. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995; 153:669-73.
23. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, McGlynn EA, Ware JE. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. JAMA 1989; 262:907-39.
24. Lukacs B, McCarthy C, Thibault P. Twelve month assessment of long term health related quality of life (HRQOL) of 5849 patients suffering from benign prostatic hypertrophy (BPH) treated by an uroselective alpha 1 blocker alfuzosin. Proceedings of the American Urological Association 1995; 155 (suppl 268A):163.
25. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Results of an epidemiological survey employing a modified American Urological Association Index for Benign Prostatic Hyperplasia in France. J Urol 1994; 151:1266-70.
26. Calaise D, Silva F, Marquis P, Deshseaux P, Gineste JL, Cauquil JP. Relative importance of sexuality and quality of life in patient with an international study. Eur Urol 1997; 31(3):272-80.
27. Quek KF, Low WY, Razack AH, Loh CS. The psychological effects of treatment for lower urinary tract symptoms. BJU International 2000; 85:630-3.
28. Quek KF, Loh CS, Low WY, Razack AH. The effects of treating lower urinary tract symptoms on sexual function. Med J Mal 2001; 56:158-66.